BioLineRx Ltd (BLRX) — Cash Flow-to-Debt Ratio
BioLineRx Ltd (BLRX) has a Cash Flow-to-Debt Ratio of -0.18x as of December 2025, meaning its operating cash flow of $-3.23 Million could theoretically repay 0% of its total liabilities ($17.56 Million) in one year. See BioLineRx Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BioLineRx Ltd Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for BioLineRx Ltd across 18 annual periods. Also explore BioLineRx Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for BioLineRx Ltd (2008–2025)
Year-by-year debt coverage analysis for BioLineRx Ltd. For market capitalisation and broader financial context, see BioLineRx Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.46x | $-8.14 Million | $17.56 Million | ▲ +73.1% |
| 2024 | -1.72x | $-43.87 Million | $25.45 Million | ▼ -286.7% |
| 2023 | -0.45x | $-22.61 Million | $50.70 Million | ▲ +56.6% |
| 2022 | -1.03x | $-26.24 Million | $25.54 Million | ▲ +42.0% |
| 2021 | -1.77x | $-23.57 Million | $13.30 Million | ▼ -92.9% |
| 2020 | -0.92x | $-23.21 Million | $25.26 Million | ▲ +18.2% |
| 2019 | -1.12x | $-22.67 Million | $20.19 Million | ▲ +30.8% |
| 2018 | -1.62x | $-24.19 Million | $14.91 Million | ▲ +36.2% |
| 2017 | -2.54x | $-20.55 Million | $8.08 Million | ▲ +31.5% |
| 2016 | -3.71x | $-14.51 Million | $3.91 Million | ▲ +3.3% |
| 2015 | -3.84x | $-14.17 Million | $3.69 Million | ▼ -16.6% |
| 2014 | -3.29x | $-14.48 Million | $4.40 Million | ▼ -34.4% |
| 2013 | -2.45x | $-20.23 Million | $8.27 Million | ▼ -13.6% |
| 2012 | -2.15x | $-20.11 Million | $9.34 Million | ▼ -30.7% |
| 2011 | -1.65x | $-11.22 Million | $6.81 Million | ▼ -192.0% |
| 2010 | 1.79x | $11.46 Million | $6.40 Million | ▲ +190.7% |
| 2009 | -1.98x | $-21.51 Million | $10.88 Million | ▲ +30.1% |
| 2008 | -2.83x | $-27.96 Million | $9.89 Million | — |